Empcogliptin
One Empcogliptin tablet combines 2 proven diabetes medications linagliptin and empagliflozin, offering the power of 2 proven treatments. Working together, empagliflozin and linagliptin can help lower A1C, along with diet and exercise. And in adults with type 2 diabetes who have known cardiovascular disease when empagliflozin (Glucolimpa), one of the medicines in Empacogliptin , is needed to reduce the risk of cardiovascular death.
Cosar® pharmaceuticals as a well-known Iranian pioneer in pharmaceutical industry for over 50 years, has continuously developed products for children, adults and seniors to help them have a healthy quality life and increase life expectancy. Our ultimate aim has been providing accessible healthcare products for people from all walks of life within and beyond the political borders.
Description of Empcogliptin
Empcogliptin
Empcogliptin 10 mg/5 mg film-coated tablets
Empcogliptin 25 mg/5 mg film-coated tablets
Empagliflozin works by inhibiting the sodium-glucose co-transporter-2 (SGLT-2) found in the proximal tubules in the kidneys. Through SGLT2 inhibition, empagliflozin reduces renal reabsorption of glucose and increases urinary excretion of glucose.
Decrease A1C
Your A1C is an average of your blood sugar over 2–3 months, and an important measure of how your type 2 diabetes treatment is going. You and your doctor will determine your personal A1C goals.
Lower fasting blood sugar
Empcogliptin has been proven to lower fasting blood sugar (the measurement taken before your first meal of the day).
Experience some weight loss
While not a weight-loss product, people taking Empcogliptin lost a bit of their body weight on average.
Based on empagliflozin is an oral medication dosed at either 10 mg daily or 25 mg daily. The recommended dose is 10 mg once daily in the morning, taken with or without food. If tolerated initially, dosing may increase up to 25 mg. Correct volume depletion, if present, before starting the drug.
Do not take Empcogliptin I if you are on dialysis.
Do not take Empcogliptin if you are allergic to linagliptin, empagliflozin, or any of the ingredients in Empcogliptin.
Inflammation of the pancreas (pancreatitis)
Ketoacidosis
Dehydration
Serious urinary tract infections
Low blood sugar (hypoglycemia)
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.